Who are follitropin alpha's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Recombinant FSH (rFSH), r-FSH (Gonal-f), gonadotopin (HMG), human menopausal gonadotropin, ovarian stimulation, Ovarian Stimulation with rFSH.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/follitropin-alpha.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

follitropin alpha — Competitive Intelligence Brief

follitropin alpha (follitropin alpha) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gonadotropin. Area: Reproductive Endocrinology.

phase 3 Gonadotropin FSH receptor Reproductive Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

follitropin alpha (follitropin alpha) — Azienda USL Modena. Follitropin alpha stimulates the production of follicle-stimulating hormone (FSH) to induce ovulation and support follicular growth.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
follitropin alpha TARGET	follitropin alpha	Azienda USL Modena	phase 3	Gonadotropin	FSH receptor
Recombinant FSH (rFSH)	Recombinant FSH (rFSH)	AGUNCO Obstetrics and Gynecology Centre	marketed	Gonadotropin	FSH receptor (FSHR)
r-FSH (Gonal-f)	r-FSH (Gonal-f)	Sisli Hamidiye Etfal Training and Research Hospital	marketed	Gonadotropin	FSH receptor (FSHR)
gonadotopin (HMG)	gonadotopin (HMG)	Yazd Research & Clinical Center for Infertility	marketed	Gonadotropin	FSH receptor (FSHR) and LH receptor (LHR)
human menopausal gonadotropin	human menopausal gonadotropin	IVI Madrid	marketed	Gonadotropin	FSH receptor (FSHR) and LH receptor (LHCGR)
ovarian stimulation	ovarian stimulation	Ain Shams Maternity Hospital	marketed	Gonadotropin	FSH receptor, LH receptor
Ovarian Stimulation with rFSH	Ovarian Stimulation with rFSH	Fundación Santiago Dexeus Font	marketed	Gonadotropin	FSH receptor (FSHR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gonadotropin class)

Instituto Valenciano de Infertilidad, IVI VALENCIA · 4 drugs in this class
Sisli Hamidiye Etfal Training and Research Hospital · 3 drugs in this class
Organon and Co · 3 drugs in this class
Fundación Santiago Dexeus Font · 3 drugs in this class
Merck KGaA · 2 drugs in this class
Nina la Cour Freiesleben · 2 drugs in this class
IVI Madrid · 2 drugs in this class
Dunamenti REK Istenhegyi IVF Center · 1 drug in this class
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology · 1 drug in this class
Azienda USL Modena · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). follitropin alpha — Competitive Intelligence Brief. https://druglandscape.com/ci/follitropin-alpha. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab